Scientech Research LLC Takes $756,000 Position in Tempus AI, Inc. (NASDAQ:TEM)

Scientech Research LLC purchased a new position in shares of Tempus AI, Inc. (NASDAQ:TEM) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 21,605 shares of the company’s stock, valued at approximately $756,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Sandia Investment Management LP purchased a new stake in Tempus AI during the 2nd quarter worth approximately $136,000. Northwestern University acquired a new stake in shares of Tempus AI in the second quarter worth approximately $491,000. Squarepoint Ops LLC purchased a new stake in shares of Tempus AI during the second quarter worth approximately $633,000. WINTON GROUP Ltd acquired a new position in Tempus AI in the 2nd quarter valued at $634,000. Finally, The Manufacturers Life Insurance Company purchased a new position in Tempus AI in the 2nd quarter valued at $946,000.

Analysts Set New Price Targets

TEM has been the subject of a number of research reports. Loop Capital initiated coverage on shares of Tempus AI in a report on Tuesday, July 9th. They set a “buy” rating and a $48.00 target price for the company. Morgan Stanley assumed coverage on shares of Tempus AI in a report on Tuesday, July 9th. They issued an “overweight” rating and a $44.00 price objective for the company. Needham & Company LLC restated a “buy” rating and set a $47.00 target price on shares of Tempus AI in a report on Wednesday, August 7th. William Blair began coverage on Tempus AI in a report on Tuesday, July 9th. They issued an “outperform” rating for the company. Finally, Bank of America started coverage on Tempus AI in a research note on Tuesday, July 9th. They set a “buy” rating and a $41.00 price objective on the stock. One equities research analyst has rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat, Tempus AI currently has a consensus rating of “Moderate Buy” and an average price target of $45.56.

Tempus AI Trading Up 3.8 %

NASDAQ:TEM opened at $53.84 on Friday. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $77.00. The company has a fifty day simple moving average of $49.63.

Tempus AI (NASDAQ:TEM) last announced its earnings results on Tuesday, August 6th. The company reported ($6.77) earnings per share for the quarter, missing the consensus estimate of ($4.41) by ($2.36). The business had revenue of $165.97 million for the quarter, compared to the consensus estimate of $159.10 million. On average, research analysts predict that Tempus AI, Inc. will post -6.51 EPS for the current fiscal year.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.